NEW YORK (GenomeWeb) – GenMark Diagnostics said after the close of the market on Monday that it has commenced a $65 million public offering of its common stock.

JP Morgan and Bank of America Merrill Lynch are joint book-running managers for the offering.  GenMark noted that it intends to grant the underwriters a 30-day option to purchase up to $9.75 million in additional shares.

The firm said that it intends to use the net proceeds from the offering for general corporate purposes and to fund its commercialization efforts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.